Although cannabinoid-based medicine has been a common treatment for headache and migraines for some time, research has been relatedly limited up until this point. A study recently published in the Journal of Pain sheds new light to cannabinoids benefits, and the findings are quite compelling.
The study set to show whether inhalation of cannabis decreased headache and migrate ratings, as well as which type of cannabis (whether concentrated in oil form or in dried flower form) was proven to be most effective.
The findings showed that headache and migraine ratings were reduced by 50% after the use of cannabinoid-based medicine; with cannabinoids in their concentrated form (oil) being related to larger reductions in headache than flower form.
The body of evidence to support the benefit of cannabinoid-based medicine is beginning to grow and we look forward to seeing more studies like this come forward.
Read the full article here.